MindWalk Holdings Corp. (HYFT) vs XBiotech Inc. (XBIT)

MindWalk Holdings Corp. and XBiotech Inc. are both Biotechnology companies. MindWalk Holdings Corp. and XBiotech Inc. are of similar size ($66.9M and $65.9M). MindWalk Holdings Corp. grew revenue faster over the last twelve months: −27.0% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −105.1%) and the higher return on invested capital (−159.2% vs −464.6%). Across the 17 metrics below, XBiotech Inc. leads on 10 and MindWalk Holdings Corp. on 7.

Valuation

Metric HYFT XBIT Biotechnology median
P/E n/m n/m 7.88
P/S 5.51 16.50 11.47
P/B 13.05 0.52 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.71 0.74
EV/Sales 5.42 (8.26) 10.73
Earnings yield (19.07%) (68.20%) (28.84%)
Free cash flow yield (13.93%) (61.95%) (23.03%)

Profitability

Metric HYFT XBIT Biotechnology median
Gross margin 60.81% 0.00% 65.16%
Operating margin (103.99%) 0.00% 0.00%
Net margin (105.06%) 0.00% 0.00%
Free cash flow margin (76.79%) 0.00% 0.00%
Return on equity (122.85%) (29.94%) (57.72%)
Return on assets (58.55%) (28.90%) (49.22%)
Return on invested capital (464.59%) (159.18%) 0.00%

Growth

Metric HYFT XBIT Biotechnology median
Revenue growth (TTM) (26.99%) (78.20%) 5.64%
EPS growth (last fiscal year) 66.15% (18.25%) —
Revenue growth, 5-year CAGR (3.83%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYFT XBIT Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 1.84 33.15 4.73
Net debt to EBITDA 0.62 2.33 0.96

Dividend

Metric HYFT XBIT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HYFT XBIT Biotechnology median
Market cap 66.90m 65.85m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack